CNTGF — Centogene NV Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Centogene NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-20.7	-21.1	-46.9	-38.6	-35.2
Depreciation
Non-Cash Items	7.24	9.88	10.9	7.97	0.605
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.9	4.56	-7.09	-6.24	-4.72
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7.78	8.46	-21.7	-26.5	-31.7
Capital Expenditures	-7.58	-16.5	-5.7	-2.09	-2.28
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	21.8	0.396	0.342	1.36	4.56
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	14.2	-16.2	-5.36	-0.733	2.28
Financing Cash Flow Items	39.9	-0.248	-0.267	-4.91	-5.99
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	25.5	14.8	-3.2	46.3	13
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	31.9	7.06	-30.3	18.1	-16.9